rxstat › Drug prices › group 0162417
group 0162417 (Ruzurgi) price in Canada
No current shortage
group 0162417 10 mg tablet costs about $18.00 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.
group 0162417 has no current shortage reported in Canada. It has been in shortage before; the history is below.
Price by province
| Strength and form | AB | SK | NB | NS |
|---|---|---|---|---|
| 10 mg Tabletper tablet | $18.00 | $18.00 | $18.00 | $18.00 |
| Plan coverage | Covered | Special approval | Special approval | Special approval |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.
Listed products by province
Alberta: 2 products
- Firdapse 10 mg Tablet · KYE
- Ruzurgi 10 mg Tablet · MDK
Saskatchewan: 2 products
- Firdapse 10 mg Tablet · KYE
- Ruzurgi 10 mg Tablet · MEC
New Brunswick: 2 products
- Firdapse 10 mg Tablet · KYE
- Ruzurgi 10 mg Tablet · MDU
Nova Scotia: 2 products
- Firdapse 10 mg Tablet · KYE
- Ruzurgi 10 mg Tablet · MDU
Shortage status
Reports by product
What's happening
There are no active shortage reports for group 0162417. Health Canada has 2 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Recent changes
- No changes recorded yet.
Common questions
How much does group 0162417 cost in Canada?
group 0162417 10 mg tablet costs about $18.00 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.
Is group 0162417 covered by provincial drug plans?
On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
When will group 0162417 be back in stock in Canada?
group 0162417 has no active shortage; supply is normal per Health Canada reports.
Why is group 0162417 in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.